On behalf of the Digital Rheumatology Network, it is a pleasure to announce the upcoming “Digital Rheumatology Day” that will take place in Berlin, Germany on May 6-7, 2022. We decided to hold the meeting in Germany to increase accessibility and to use Berlin as a digital hub. In addition, Germany is currently playing a pioneering role in digital therapies, among other things.
The aim of this meeting in the thriving field of digitalization is to connect a wide variety of disciplines, notably rheumatologists, specialists, Pharma and MedTech industry, associations and consultants. Our efforts have shown us, that all these stakeholders want to be prepared for the ongoing digital transformation.
The 4th Digital Rheumatology Day will take place hybrid – live and virtual. Notwithstanding, we will make every effort to attract a maximum of participants on site in order to increase the exchange of knowledge. We will also hold various workshops that can only be attended on site.
Topics this year will be (all with a focus on rheumatology):
- New digital solutions and user preferences
- New Apps and digital therapies in the field
- AI & self-learning systems
- Telemonitoring & PRO’s
- Digital biomarkers
- Analysing the online health community
- Pitching Event for providers and developers of digital care solutions that can improve quality of care in rheumatology
- Workshops on AI, LinkedIn and Twitter and DIGAs
We look forward welcoming you!
The Board Members of the Digital Rheumatology Network
Prof. Thomas Hügle
Department of Rheumatology, University Hospital Lausanne, Switzerland
Prof. Jacob M. van Laar
Rheumatology & Clinical Immunology, University Medical Centre Utrecht, Netherlands
Prof. Jutta Richter
Department Rheumatology & Hiller-Research Unit Rheumatology, University Hospital Düsseldorf, Germany
Prof. Didier Hans
Department of Rheumatology, University Hospital Lausanne, Switzerland
Dr. Johannes Knitza
University Hospital Erlangen, Germany
Dr. Martin Krusche
Center of Internal Medicine, University Hospital Hamburg (UKE), Germany
Dr. Latika Gupta
Royal Wolverhampton Hospitals NHS Trust / University of Manchester, United Kingdom
FRIDAY I MAY 6 I 17:00 – 19:30
17:00 – 17:10
Johannes Knitza, Thomas Hügle, Martin Krusche
17:10 – 17:30
Legislative Outlook of Digital Health Applications
Johannes Fechner, Member of the German Parliament
17:30 – 17:50
Digital Transformation in Rheumatology
Gerd Burmester. Berlin
17:50 – 18:10
Clinical impact of a digital behavioral therapy for fibromyalgia management: a randomized controlled trial
Stephanie Catella, San Francisco
18:10 – 18:30
Smartphone Assisted Patient Initiated Care Safely Reduces Outpatient Clinic Visits in Patients with Rheumatoid Arthritis: Results from a Randomized Controlled Trial
Bart Seppen, Amsterdam
18:30 – 18:50
Improving care and capacity through capturing and recording electronic patient reported outcomes with digital solutions in inflammatory arthritis
Antoni Chan, Reading
18:50 – 19:20
Discussion round: Quo Vadis Digital Therapeutics?
Randy Horton, Miami-Fort Lauderdale I Saemundur Oddsson, Göteborg I Thomas Hügle, Lausanne I Johannes Knitza, Erlangen I Martin Krusche, Hamburg
– Networking dinner –
SATURDAY I MAY 7 I 08:30 – 15:30
08:30 – 09:30
Workshop I: Optimize your communication via LinkedIn & Twitter I Dr. Thomas Wilckens, Berlin
There is a growing importance of social media for doctors. Platforms like LinkedIn or Twitter provide HCPs with tools to share information, to debate health care policy and practice issues, to promote health behaviors, to engage with the public, and to educate and interact with patients, caregivers, students, and colleagues. In this workshop you will learn the most important tools how to use Twitter and LinkedIn in the most effective way.
Workshop II: My first steps in using artificial intelligence I Lyudmil Pelov, Hamburg & Robin Vaaler, Zurich
– supported by Oracle –
The aim of this workshop is to demystify the term AI by giving you a high level overview of the most used approaches and outline how they can be applied in the medical domain. We will point out some of the common pitfalls and misunderstandings and show you how the first steps of applying AI could look like.
Workshop III: Virtual reallity in Rheumatology I Dr. Philipp Klemm, Giessen
– supported by Eli Lilly SA –
The use of virtual reality enables a disease-specific knowledge visualization and may add a new educational pillar to conventional educational approaches. Get some background knowledge about this new technology and try the devices yourself!
Workshop VI: BerlinCaseViewer I Prof. Kay-Geert Hermann, Berlin
In the field of rheumatology, we are confronted with complex cases every day. Learn with BerlinCaseViewer about a modern imaging of rheumatic diseases. The app offers a unique learning experience based on genuine cases with authentic medical image data sets directly on your device.
09:40 – 10:00
Presentation winner of the „Digital Rheumatolology Research Award“
Session I: Apps and Digital Therapies (DTX)
chairs: Thomas Hügle and Johannes Knitza
10:00 – 10:20
The importance of user experience in the development of digital therapeutics
Marc Blanchard, Lausanne
10:20 – 10:40
Mobile Responsive App-A Useful Additional Tool for Data Collection in the German Pregnancy Register Rhekiss
Jutta Richter, Düsseldorf
10:40 – 11:00
App-enhanced therapy for patients with inflammatory arthritis – first results from a pilot study
Jan Leipe, Mannheim
– coffee break –
Session II: Telemedicine & Wearables
chairs: Latika Gupta and Martin Krusche
11:30 – 11:50
Virtual and augmented reality to enhance patient communication
Philipp Klemm, Giessen
11:50 – 12:10
Specifity and Sensitivity of virtual video consultations
Matteo Piga, Cagliari
12:10 – 12:30
Overcoming barriers using telemedicine, the case for myosits
Rohit Aggarwal, Utah
12:30 – 12:50
Objective measurement of physical activity and sedentary behavior using wearable devices in patients with axial spondyloarthritis
Julie Soulard, Quebec
– Networking Lunch
Session III: AI & Self-Learning Systems
chairs: Jutta Richter and Thomas Hügle
13:30 – 13:50
AI in Rheumatology- Hype or Hope
Koray Tascilar, Erlangen
13:50 – 14:10
Machine to differentiate between RA /PsA and PsO based on MRI data
David Simon, Erlangen
14:10 – 14:30
Potential of AI-based conversational agents (chatbots)
Alexandra Lehmann, Bayreuth
14:30 – 14:50
Fabian Proft, Berlin
14:50 – 15:20
Session IV: Pitching Event for New Digital Solutions
chair: Johannes Knitza
Presentations of the 3min elevator pitch videos submitted by providers and developers of digital care solutions that (could) improve quality of care in rheumatology
Discussion & winner voting
15:20 – 15:30 Farewell
Prof. Matteo Piga
University of Cagliari
Matteo Piga, MD, is an associate professor in Rheumatology . He was with the Lupus Unit of St. Thomas’s Hospital, London (U.K.), as an Honorary Research Fellow, between 2007 and 2008, and in 2011 he has joined the University of Cagliari (Italy). His major research interests include developing tools for the assessment of organ damage and disease activity in rheumatic diseases, especially in Systemic Lupus Erythematosus and Behçet’s disease, and implementing telemedicine and musculoskeletal ultrasound in diagnosis and therapeutic monitoring of chronic inflammatory rheumatic diseases. He has also contributed to more than 100 publications in the field of rheumatic diseases.
Dr. Julie Soulard
Interdisciplinar Research Center on Rehabilitation, Montreal, Canada
Julie Soulard is a French physiotherapist, who is particularly involved in research on gait analysis with wearable sensors. She combines clinical and research activities, associated to teaching for physiotherapy and medical students. She defended her PhD on gait and axial apondyloarthritis in February 2021. She is now conducting a post doctoral internship 2022 in the Interdisciplinar Research Center on Rehabilitation in Montréal.
Dr. Antoni Chan
Royal Berkshire NHS Foundation Trust and
Spire Dunedin Hospital, Reading, United Kingdom
Antoni Chan is a Consultant Rheumatologist and Associate Medical Director at the Royal Berkshire NHS Foundation Trust. He did his PhD in immunology Oxford. He is the Trust and Berkshire West ICP clinical lead for Outpatient Transformation. He is Clinical Lead for the Spondyloarthritis service in his Trust. He is a Visiting Fellow of the Henley Business School, University of Reading. He was awarded the British Society for Rheumatology Best Practice Award for setting up the Integrated Pain Assessment and Spinal Service (IPASS). His team won the National Axial Spondyloarthritis Society (NASS) Aspiring to Excellence Award. He received the Patient Choice Award for Best Care by a Rheumatologist from NASS in the Houses of Parliament. He is Trustee and Medical Advisory Board Member of NASS. He is a full member of ASAS and Primary Investigator for clinical trials in his department.
Reade, Amsterdam, The Netherlands
Bart Seppen is a medical graduate student at Reade Rheumatology in Amsterdam. Together with Wouter Bos, Jim Wiegel and Brightfish B.V. he is working on the development of the MijnReuma Reade app and its integration into daily clinical practice. His research focusses on the implementation of this app and the adherence to eHealth interventions in rheumatology.
Dr. Stephanie Catella
Bay Area Trauma Recovery Clinic, San Francisco, USA
Dr. Stephanie Catella is a clinical lead and consultant to innovative healthcare and tech companies, creating evidence-based therapy programs and helping bridge technology with healthcare. As a licensed clinical psychologist, she provides cutting edge, transdiagnostic Cognitive Behavioral Therapy and Acceptance and Commitment Therapy to those suffering from trauma, depression, anxiety, chronic pain and other chronic medical illnesses. Dr. Catella completed her post-doctoral residency in behavioral health at the San Francisco VA and a research fellowship at the University of California, San Francisco.
Dr. Fabian Proft
Universitätsklinikum Charité, Berlin, Germany
Fabian Proft (MD) is a rheumatologist working at the Charité University Hospital Berlin in Germany. He has received his medical degree at Munich University, where he also started his medical training and later on rheumatological specialization. Since 2016 he is working in the Department of Prof. Denis Poddubnyy at Charité Berlin at an dedicated ASAS center as senior researcher and Head of the Clinical Trials Unit. His main research topics are axial Spondyloarthritis and Psoriatic Arthritis with a strong focus on randomized controlled trials, digitalization, outcome measures and imaging. He published numerous research articles, reviews and book chapters focusing on Spondyloarthritis. Recently, one of his scientific focusses lies on early detection of Spondyloarthritis by patient centered digital applications and the use of artificial intelligence for imaging assessment in patients with suspicion of axial Spondyloarthritis. He is an active member of ASAS and GRAPPA and he is part of the EMEUNET Education subgroup. Furthermore, he is the chair of Young-GRAPPA 2021-2024 and one of the Young-ASAS leaders 2021-2023.
Prof. Kay-Geert Hermann
Alexandra Lehmann, M.Sc.
Universität Bayreuth, Germany
Alexandra Lehmann is a research associate at the department of Health Economics at the University of Bayreuth. During her studies, she spent a semester abroad at the University of Michigan and was co-organizer of a conference on Global Health in Johannesburg. She also worked in the medical technology industry for several years and has completed various internships in the healthcare industry. In her spare time, she volunteers as an active member of the working group for Health Economics and Management of the German Society for Integrated Care and Hashtag Health
University Hospital Lausanne, Switzerland
Marc Blanchard is a life-science PhD student in the Rheumatology department of the Lausanne University Hospital (CHUV). His thesis, which started in February 2021 and is directed by Prof. Thomas Hügle, aims to develop a digital therapeutic solution for patients suffering from post-COVID19 syndrome. So far, his work has been mostly focused on the technical aspects required to develop a reliable therapeutic software as well as on User Experience (UX) research and User Interface (UI) development. The next step consists of a clinical assessment of the efficacy of the software and its therapeutic content.
Dr. Jan Leipe
University Clinic Mannheim, Germany
Jan Leipe, MD, is a specialist in internal medicine and rheumatology. He is Head of the Division of Rheumatology at the University Clinic Mannheim, and an immunologist of the German Society for Immunology
Dr. Johannes Fechner
German Parliament, Berlin, Germany
Johannes Fechner (b. 1972 in Freiburg im Breisgau, Germany) is a German lawyer and Member of the German Bundestag (SPD) since 2013 for the electoral constituency Emmendingen-Lahr. After his studies of law at Albert Ludwig University of Freiburg (1993-1998), he attained a doctorate degree in law (2001). He has been working as a lawyer in Emmendingen ever since. From 2014 to 2021 he served as the spokesperson on legal affairs of the SPD parliamentary group. After the 2021 elections, he took part in the negotiations to form the “traffic light” coalition. Johannes Fechner was elected in December 2021 as a parliamentary manager, the legal adviser and the spokesperson of the SPD parliamentary group for the scrutiny of elections, immunity and the rules of procedure. He is a sports aficionado and a proud player of FC Bundestag.
Dr. Philipp Klemm
Kerckhoff Klinik, Giessen, Germany
Dr. Philipp Klemm is a rheumatologist at Kerckhoff Klinik and Justus-Liebig-Univeristy Gießen. In his research he focusses on digitalization, mainly he is invested into augmented and virtual reality and how it can change patient communication. He thinks that the gap to close lacking adherence is a different approach with the patient using digitalisation and making the patient understand what rheumatic diseases can cause and what they mean for the individual.
Dr. Saemundur Oddsson
Sidekick Health, Göteborg, Sweden
Dr. Sam Oddsson is Sidekick’s co-founder and chief medical officer. Oddsson practiced internal medicine for several years at Northern Europe’s largest teaching hospital, Sweden’s Sahlgrenska University Hospital. Sam is also an accomplished researcher and author of several peer-reviewed articles in the areas of obesity, cardiovascular disease, and lung disease. He is a member of the Swedish Society of Cardiology.
Prof. Gerd Burmester
Universitätsklinikum Charité, Berlin, Germany
Gerd R. Burmester, MD, is Professor of Medicine and Rheumatology and Senior Professor in the Department of Rheumatology and Clinical Immunology at the Charité – Universitätsmedizin Berlin, Freie Universität und Humboldt-Universität Berlin.
Professor Burmester earned his medical degree from Hannover Medical School and completed a residency at the Medical School of the University of Erlangen-Nürnberg. He was awarded a postdoctoral fellowship at Rockefeller University in New York and was a visiting scholar at the Hospital for Joint Diseases, Mount Sinai School of Medicine, New York, New York.
Professor Burmester is the recipient of numerous awards, including the Jan van Breemen Medal of the Dutch Society of Rheumatology and the Carol-Nachman Price for Rheumatology. He serves on several editorial boards, including the Journal of Rheumatology and Clinical Rheumatology, and he is the Associate Editor of Annals of the Rheumatic Diseases, official journal of EULAR. The author himself of more than 900 original and review articles, Professor Burmester’s research interests include rheumatoid arthritis, Lyme borreliosis, immunotherapy, cellular activation mechanisms in inflammatory joint diseases, and tissue engineering. Professor Burmester served as President of the German Society of Rheumatology from 2001-2002. He was a Member of the Executive Committee of the European League against Rheumatism from 2003-2006 acting as Chairman of the Standing Committee on Investigative Rheumatology and became an honorary member of EULAR in 2006. From 2011 – 2013 he served as Treasurer of EULAR, and he was elected President Elect of EULAR in 2013. From 2015 – 2017 he was President of EULAR and served as Immediate Past President of EULAR until 2019. Since 2017 he is President of the Board of Trustees, FOREUM Foundation for Research in Rheumatology. In 2019 he became Master of the American College of Rheumatology.
Orthogonal, Miami-Fort Lauderdale, USA
Randy Horton is VP of Solutions and Partnerships at Orthogonal, a software development consulting firm. Orthogonal helps MedTech firms improve patient outcomes faster by accelerating their development pipelines for Software as a Medical Device (SaMD), digital therapeutics (DTx) and connected medical device systems.
Randy Horton is passionate about helping established organizations break through to their “what’s next” by building new capabilities and launching new products and services that are both innovative and successful. Much of his career has focused on using digital health to tackle The Quadruple Aim: 1) Improving the individual experience of care, 2) Improving the health of populations, 3) Reducing the per capita costs of care, and 4) Improving the work life of those who deliver care.
Horton currently serves as co–chair of the following AAMI standards efforts:
- AAMISoftware Management Working Group (SM-WG) 10 – Cloud Computing
- AAMI CR:510(2021): Consensus Report on the Appropriate Use of Public Cloud Computing for Quality Systems and Medical Devices
- AAMITechnical Information Report (TIR) #115, which is advancing the work first published in AMI CR:510(2021)
Horton earned a BA in History from the University of Michigan – Ann Arbor and was in the first graduating class of Masters students from the University of Michigan’s School of Information.
Randy credits much of his passion for creative business thinking and being a connector of people and ideas to his formative time at a Montessori pre-school.
l-being of our patients.
Dr. David Simon
University Hospital Erlangen, Germany
Dr. David Simon is a Senior Clinician Scientist with extensive experience in clinical and imaging research. His particular scientific focus lies on early arthritis detection, innovative imaging, and conducting clinical trials. He is Principal Investigator of several studies and recipient of various awards such as the Else Kröner-Memorial Scholarship 2019 (Else Kröner-Fresenius Stiftung), the Ideenwettbewerb 2019 (Deutsche Rheumastiftung), the Wissenschaftspreis 2020, Wissenschaftspreis 2021 (Arbeitsgemeinschaft Junge Rheumatologie – rheumadocs, Deutsche Gesellschaft für Rheumatologie e.V. (DGRh)) or the Carol-Nachman-Nachwuchs-Forschungspreis 2021 (Deutsche Rheumastiftung). Dr. David Simon has published more than 80 scientific papers in prestigious international journals (e.g. Nature, Nature Communications, Annals of the Rheumatic Diseases, Arthritis & Rheumatology, etc.).
Prof. Rohit Aggarwal
University of Utah / University of Pittsburgh, USA
Dr. Aggarwal is a professor of medicine at University of Pittsburgh and medical director of Arthritis and Autoimmunity Center at University of Pittsburgh Medical Center. He is the co-Director of UPMC Myositis Center. His research and clinical areas of interest are clinical and translational research in inflammatory muscle diseases (myositis) and associated interstitial lung disease. He is the past-chair of the medical advisory board of The Myositis Association (TMA) as well as past-chair of the scientific committee of IMACS, which are the largest patient and physician groups working in the field of myositis, respectively.
Dr. Aggarwal is an established independent clinical investigator with significant funding
from NIH, foundations and industry and currently leading several collaborations
internationally with other key leaders in the world. He has maintained an extremely high
publication record and received national and international recognition of his work. He
continues to be a leader in disease criteria and outcomes measures in myositis as well as in clinical trials of novel therapeutic agents for myositis. He is currently the principal
investigator or member of the steering committee for several international phase 2/3
clinical trials in the area of myositis and associated ILD. Dr. Aggarwal is also mentoring
future generation of rheumatologist with great success and attracting younger
rheumatologist towards myositis research for the advancement of the field. Dr. Aggarwal lectures at various international conferences and promotes patient education through his YouTube channel.
Oracle, Zürich, Switzerland
Robin Vaaler is a senior researcher at Oracle Labs. He received his Msc in computer science at ETH Zurich and has broad expertise in machine learning and deep learning. At Oracle Labs, his research is focused on applied machine learning. He works on integrating recent progress in the fields of Deep Learning, AutoML, and GraphML into software tools and products. His personal mission is to empower organizations, scientists, and developers to successfully deploy AI in the real world. Throughout his career he has been involved in multiple AI projects in the medical domain.
Oracle, Hamburg, Germany
Lyudmil Pelov is Senior Principal Product Manager for the AI and Data Science Platform in Oracle Cloud, which is evolving to become the common AI/ML platform for enterprise customers, cognitive AI services, and machine learning use cases in the Oracle Cloud. Lyudmil joined Oracle during the BEA acquisition in 2007 and has gained extensive experience building and leading successful engineering projects delivering highly scalable cloud-based and on-premises solutions across a variety of domains.
Dr. Koray Tascilar
University Hospital Erlangen, Germany
Koray Tascilar is a rheumatologist currently working as a clinical research scientist in Universitätsklinikum Erlangen with a focus on clinical study design and data analysis.
Sponsors & Partners 2022
H4 Hotel Alexanderplatz
Karl-Liebknecht- Strasse 32
10178 Berlin, Germany
Who should attend?
The Digital Rheumatology Day connects leading experts from a wide variety of disciplines like physicians (Rheumatologists, Radiologists, Rehabilitation, Internal Medicine, Immunologists), patients, pharma and MedTech industry, Health IT companies, associations, consultants and academia as well as research centers to discover new innovative practices.
The meeting will be held in English.
8 CME credits from credits Swiss Society of Allergologie and Immunology (SSAI)
8 CME credits from Swiss Society of Physical Medicine and Rehabilitation (SGPMR)
8 CME credits from Swiss Society of Rheumatology (SRG)
Comeed – Medical Conferences, Meetings & Education Sina Reis-Balikcioglu
Please note: You can join the workshops on site only. They will not be transmitted online.
Please push “load content” to see the registration tool.